Multicentric trial of low molecular weight heparin (LMWH) plus low dose aspirin efficacy versus only low dose aspirin for prevention of recurrent preeclamsia.
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2013
At a glance
- Drugs Enoxaparin sodium (Primary) ; Aspirin
- Indications Preeclampsia; Thrombosis
- Focus Therapeutic Use
- 20 Jul 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 06 Aug 2011 New trial record